With the adjustment of the zero-COVID policy, the positive rates of FluB and BoV were highest in Phase II, while HRV and HPIV showed an increasing trend in positive rates in Phases II and III.
← all excerpts
Inhibition, transition, and surge: dynamic evolution of pediatric respiratory pathogen trends amid COVID-19 pandemic policy adjustments.
1
—
—